Identifying inhibitors of NF-κB is of great interest for the treatment of cancer and inflammatory diseases, due to the ability of NF-κB to promote the survival of cancer cells in response to chemotherapeutic agents and to the pro-inflammatory effects of NF-κB signaling [32,36]. This evidence concerns the gene NFKB1 and cancer.